{"news_desk": "Business", "print_page": "6", "section_name": "Business Day", "subsection_name": null, "byline": {"original": "By KATIE THOMAS", "person": [{"rank": 1, "role": "reported", "firstname": "Katie", "organization": "", "lastname": "THOMAS"}]}, "abstract": "Teva Pharmaceutical Industries announces settlement of $512 million over claims by drug wholesalers and other companies that subsidiary Cephalon paid generic manufacturers to keep their cheaper versions of drug off market; settlement, largest ever paid to direct purchasers of drugs, must be approved by judge.", "type_of_material": "News", "word_count": "572", "lead_paragraph": "A lawsuit claimed that Cephalon, a subsidiary of Teva Pharmaceuticals, had paid generic manufacturers to keep a cheaper version of a drug off the market.", "pub_date": "2015-04-21T00:00:00Z", "document_type": "article", "slideshow_credits": null, "headline": {"main": "Teva to Pay $512 Million to Settle Suit Over Delay of Sleep Disorder Drug", "print_headline": "Teva to Pay $512 Million to Settle Suit Over Delay of Sleep Disorder Drug"}, "snippet": "A lawsuit claimed that Cephalon, a subsidiary of Teva Pharmaceuticals, had paid generic manufacturers to keep a cheaper version of a drug off the market.", "multimedia": [{"height": 126, "url": "images/2015/04/21/business/21SETTLE/21SETTLE-thumbWide.jpg", "legacy": {"widewidth": "190", "wideheight": "126", "wide": "images/2015/04/21/business/21SETTLE/21SETTLE-thumbWide.jpg"}, "type": "image", "width": 190, "subtype": "wide"}, {"height": 400, "url": "images/2015/04/21/business/21SETTLE/21SETTLE-articleLarge.jpg", "legacy": {"xlargewidth": "600", "xlargeheight": "400", "xlarge": "images/2015/04/21/business/21SETTLE/21SETTLE-articleLarge.jpg"}, "type": "image", "width": 600, "subtype": "xlarge"}, {"height": 75, "url": "images/2015/04/21/business/21SETTLE/21SETTLE-thumbStandard.jpg", "legacy": {"thumbnailwidth": "75", "thumbnail": "images/2015/04/21/business/21SETTLE/21SETTLE-thumbStandard.jpg", "thumbnailheight": "75"}, "type": "image", "width": 75, "subtype": "thumbnail"}], "web_url": "http://www.nytimes.com/2015/04/21/business/teva-to-pay-512-million-to-settle-suit-over-delay-of-sleep-disorder-drug.html", "keywords": [{"rank": "1", "is_major": "Y", "value": "Teva Pharmaceutical Industries Ltd", "name": "organizations"}, {"rank": "2", "is_major": "Y", "value": "Cephalon Inc", "name": "organizations"}, {"rank": "3", "is_major": "Y", "value": "Generic Brands and Products", "name": "subject"}, {"rank": "4", "is_major": "N", "value": "Drugs (Pharmaceuticals)", "name": "subject"}, {"rank": "5", "is_major": "N", "value": "Federal Trade Commission", "name": "organizations"}], "blog": [], "_id": "5535a20c38f0d821accece45", "source": "The New York Times"}